Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.78
+0.20 (3.04%)
At close: Mar 27, 2026

HKG:0512 Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,28311,64510,5309,5628,598
Revenue Growth (YoY)
5.48%10.59%10.12%11.22%35.34%
Cost of Revenue
5,5034,9074,0063,6113,351
Gross Profit
6,7806,7386,5245,9515,247
Selling, General & Admin
5,1964,6213,8023,3963,307
Other Operating Expenses
-224.01-176.83-195.17-170.42-242.12
Operating Expenses
5,0114,5173,6653,2033,077
Operating Income
1,7702,2212,8602,7482,170
Interest Expense
-162.34-180.24-205.15-137.49-92.96
Interest & Investment Income
-6.317.7519.8174.95
Earnings From Equity Investments
76.06148.72-25.01-43.79113.86
Other Non Operating Income (Expenses)
--27.78-32.3440.1-8.35
EBT Excluding Unusual Items
1,6832,1682,6052,6272,258
Merger & Restructuring Charges
--1.3--0.22-
Impairment of Goodwill
--49.07-39.14-36.44-
Gain (Loss) on Sale of Investments
-189.31675.9389.27-94.62484.85
Gain (Loss) on Sale of Assets
----2.37
Asset Writedown
-4.395.4521.3529.58
Other Unusual Items
-54.21-316.18-11.42
Pretax Income
1,4942,8522,3442,5172,786
Income Tax Expense
249.78386.3448.76418.64380.8
Earnings From Continuing Operations
1,2442,4661,8952,0982,405
Minority Interest in Earnings
-3.432.32-15.44-18.83-2.47
Net Income
1,2412,4681,8802,0792,403
Net Income to Common
1,2412,4681,8802,0792,403
Net Income Growth
-49.73%31.30%-9.59%-13.45%34.02%
Shares Outstanding (Basic)
3,5023,5023,5083,5423,548
Shares Outstanding (Diluted)
3,5023,5023,5083,5423,548
Shares Change (YoY)
--0.17%-0.97%-0.16%2.98%
EPS (Basic)
0.350.700.540.590.68
EPS (Diluted)
0.350.700.540.590.68
EPS Growth
-49.73%31.52%-8.70%-13.31%30.14%
Free Cash Flow
-1,3421,9371,2161,534
Free Cash Flow Per Share
-0.380.550.340.43
Dividend Per Share
0.1690.2600.2600.1400.110
Dividend Growth
-35.00%-85.71%27.27%-
Gross Margin
55.20%57.87%61.96%62.24%61.03%
Operating Margin
14.41%19.07%27.16%28.74%25.24%
Profit Margin
10.10%21.20%17.85%21.75%27.94%
Free Cash Flow Margin
-11.53%18.40%12.72%17.84%
EBITDA
2,2232,6753,2123,1092,493
EBITDA Margin
18.10%22.97%30.50%32.52%28.99%
D&A For EBITDA
453.38453.38352.36361.05322.53
EBIT
1,7702,2212,8602,7482,170
EBIT Margin
14.41%19.07%27.16%28.74%25.24%
Effective Tax Rate
16.72%13.54%19.14%16.63%13.67%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.